Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

If nothing is brewing behind the scene then we are screwed because another dilution at the current price would cripple shareholders and erase years of progress the company has made in terms what shareholders see. I think the market sees that worse case scenario because the company sold a whopping 20% of the company for $2/$20m. I still think something is going on because they would have already named a CEO if they wanted to stay independent. At fire sale price, I think the company would command at least $300m/$6 share price given we are phase 3 and have a deal with Amgen that could higher future milestones. Selling the company at that price would be more in our interests than doing another dilution on terrible terms IMO.